Highview Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Highview Capital Management's LLY Position: Q2 2026 in Review
Highview Capital Management increased its Eli Lilly (LLY) stake by 5.7% in Q2 2026, buying an estimated $336K and bringing the position to 6,087 shares worth $7.3M. The position accounts for 2.1% of the portfolio, ranked #11.
Highview Capital Management first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Highview Capital Management held 6,087 shares of Eli Lilly worth $7.3M as of Q2 2026.
- Highview Capital Management bought 329 Eli Lilly shares in Q2 2026, an estimated $336K.
- Eli Lilly made up 2.1% of Highview Capital Management's portfolio in Q2 2026, its #11 holding.
- Highview Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Highview Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.